Greater Cannabis Company, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
FL
Business Address
15 WALKER AVE,, BALTIMORE, MD, 21208
Mailing Address
15 WALKER AVE,, BALTIMORE, MD, 21208
Phone
(443) 738-4051
Fiscal Year End
1231
EIN
300842570
Financial Overview
FY2025
$898K
Total Liabilities
-$661K
Stockholders' Equity
$0.00
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 12, 2025 | View on SEC |
| 8-K Current report of material events | October 27, 2025 | View on SEC |
| 8-K/A Current report amendment | October 16, 2025 | View on SEC |
| 8-K Current report of material events | October 15, 2025 | View on SEC |
| 10-Q/A Quarterly report amendment | August 8, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 8, 2025 | View on SEC |
| 10-Q Quarterly financial report | May 12, 2025 | View on SEC |
| 10-K/A Annual report amendment | May 5, 2025 | View on SEC |
| 8-K Current report of material events | April 10, 2025 | View on SEC |
Annual Reports
10-K
March 31, 2026
- Holds an exclusive global license from the Hebrew University of Jerusalem for unique cannabinoid formulas.
- Targeting high-growth medical markets including autism, Parkinson’s, and Alzheimer’s.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.